The eye area: why it ages differently and which ingredients are actually worth using there

Why the periorbital area is anatomically distinct from the rest of the face

The skin around the eyes (the periorbital area) is anatomically different from the skin on the cheeks, forehead and chin in four ways that directly determine how it ages and how it responds to skincare. It is the thinnest skin on the face — approximately 0.5mm compared to 2mm on the cheeks — which means mechanical stress from blinking (approximately fifteen thousand blinks per day) produces more deformation per unit of skin area than the same movement would on thicker facial skin. It has few sebaceous glands, making it inherently drier and more prone to the transepidermal water loss that accelerates collagen degradation. The blood vessels beneath the periorbital skin are close to the surface and structurally different, producing the visible blue-purple discolouration that most people call dark circles. And the orbicularis oculi muscle responsible for the repeated contraction-relaxation cycle of blinking is attached directly to the overlying skin, creating the mechanical force responsible for crow's feet in a way that has no equivalent elsewhere on the face.

Dark circles: three different causes that require three different approaches

The umbrella term "dark circles" encompasses at least three distinct phenomena. Vascular dark circles — the most common type — appear as blue-purple discolouration from blood vessels visible through thin, translucent periorbital skin; they are more prominent with fatigue (which dilates blood vessels), dehydration and aging (which thins the overlying skin further). Pigmented dark circles are post-inflammatory or UV-induced melanin deposits in the periorbital skin, appearing brown rather than purple and responding to the same brightening approach as hyperpigmentation elsewhere on the face. Structural dark circles are shadows from the tear-through groove or loss of orbital fat volume, producing a hollow below the orbital rim that casts a shadow in normal lighting — this type does not respond to topical treatment because the cause is structural (volumetric) rather than pigmentary or vascular. Identifying which type (or which combination) applies determines which treatments are relevant and which are not.

Peptides and PDRN for structural aging around the eyes

The crow's feet that form at the outer corners of the eyes from repeated muscle contraction are mechanical wrinkles — they follow the fold lines created by orbicularis oculi contraction and cannot be prevented by skincare that does not influence muscle mechanics. What skincare can do is improve the structural integrity of the skin that the muscle is folding, so that the fold lines are less visible at rest and recover more completely when the face relaxes. Peptides that stimulate collagen production (palmitoyl tripeptide, acetyl hexapeptide) address the structural skin beneath the fold line, improving its ability to rebound after deformation. PDRN-stimulated fibroblast activity increases the collagen density in the periorbital dermis, providing more material for the skin to hold its shape with after each blink cycle. Neither approach eliminates crow's feet; both reduce their resting-state visibility over months of consistent application.

Application technique for the periorbital area: less product, more precision

The eye area requires less product than the cheeks or forehead — thin skin absorbs small amounts very efficiently, and over-application of heavy creams or high-concentration actives increases the risk of milia (keratin-filled cysts) in the periorbital skin, which lacks the sebaceous gland activity to process excess emollients. A small amount — a grain-of-rice-sized drop — of PDRN or peptide ampoule applied to each eye area with the ring finger (which exerts less pressure than the index finger or middle finger) and pressed gently rather than rubbed produces adequate coverage without the mechanical stress of vigorous rubbing. Apply from the outer corner inward (against the direction of the most significant skin movement), following the periorbital bone rather than the puffier orbital area above and below which tends to benefit from lighter application.

What causes under-eye puffiness and what does and does not help it

Morning periorbital puffiness has two common causes. Fluid accumulation in the loose connective tissue under the eye during sleep (which drains when the head is elevated during the day) produces transient puffiness that reduces within thirty to sixty minutes of being upright. Chronic puffiness from fat pad herniation through the orbicularis muscle (a structural change) produces constant puffiness that does not drain away and does not respond to topical treatment. For transient fluid-accumulation puffiness, cold compresses, caffeine-containing eye products (which temporarily vasoconstrict and reduce fluid) and elevation (sleeping with the head slightly elevated) all provide some reduction. A PDRN ampoule applied in the morning to periorbital skin does not reduce puffiness directly — its collagen-stimulating activity operates on a longer timeline — but consistent use over months strengthens the orbicularis fascia and periorbital skin enough that the herniation of fluid through the tissue occurs less readily.